Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-026630
Filing Date
2025-03-21
Accepted
2025-03-21 16:01:08
Documents
2
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm259829-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm259829-1_3seq1.xml 3 1683
2 EXHIBIT 24 tm259829d1_ex24.htm EX-24 8364
  Complete submission text file 0001104659-25-026630.txt   11601
Mailing Address C/O SERESTHERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
von Moltke Lisa (Reporting) CIK: 0001808592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42270 | Film No.: 25760381

Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)